Cardiovascular magnetic resonance in patients with pectus excavatum compared with normal controls.

PURPOSE: To assess cardiothoracic structure and function in patients with pectus excavatum compared with control subjects using cardiovascular magnetic resonance imaging (CMR). METHOD: Thirty patients with pectus excavatum deformity (23 men, 7 women, age range: 14-67 years) underwent CMR using 1.5-Tesla scanner (Siemens) and were compared to 25 healthy controls (18 men, 7 women, age range 18-50 years). The CMR protocol included cardiac cine images, pulmonary artery flow quantification, time resolved 3D contrast enhanced MR angiography (CEMRA) and high spatial resolution CEMRA. Chest wall indices including maximum transverse diameter, pectus index (PI), and chest-flatness were measured in all subjects. Left and right ventricular ejection fractions (LVEF, RVEF), ventricular long and short dimensions (LD, SD), mid-ventricle myocardial shortening, pulmonary-systemic circulation time, and pulmonary artery flow were quantified. RESULTS: In patients with pectus excavatum, the pectus index was 9.3 ± 5.0 versus 2.8 ± 0.4 in controls (P < 0.001). No significant differences between pectus excavatum patients and controls were found in LV ejection fraction, LV myocardial shortening, pulmonary-systemic circulation time or pulmonary flow indices. In pectus excavatum, resting RV ejection fraction was reduced (53.9 ± 9.6 versus 60.5 ± 9.5; P = 0.013), RVSD was reduced (P < 0.05) both at end diastole and systole, RVLD was increased at end diastole (P < 0.05) reflecting geometric distortion of the RV due to sternal compression. CONCLUSION: Depression of the sternum in pectus excavatum patients distorts RV geometry. Resting RVEF was reduced by 6% of the control value, suggesting that these geometrical changes may influence myocardial performance. Resting LV function, pulmonary circulation times and pulmonary vascular anatomy and perfusion indices were no different to controls.

High-spatial-resolution lower extremity MR angiography at 3.0 T: contrast agent dose comparison study.

PURPOSE: To determine whether contrast material dose reduction at 3.0 T allows preserved image quality for high-spatial-resolution magnetic resonance (MR) angiography of the lower extremities. MATERIALS AND METHODS: Forty-five consecutive patients (27 men, 18 women; mean age, 64 years) underwent contrast material-enhanced MR angiography of the lower extremities at 3.0 T. A waiver of informed consent was granted by the institutional review board. Sixteen patients received high-dose (approximately 0.3 mmol/kg), 15 received intermediate-dose (approximately 0.2 mmol/kg), and 14 received low-dose (approximately 0.1 mmol/kg) gadopentetate dimeglumine during a three-station, dual-injection examination. For scoring purposes, the arterial system from the celiac trunk to the plantar arteries was divided into 34 segments. The images were retrospectively and independently evaluated by two specialized radiologists who were blinded to the patient dose groups. All studies were assessed for overall image quality and the degree of contaminating venous enhancement. Each arterial segment was scored for the quality of vessel definition, the severity of stenoses, and the presence of collateral vessels. RESULTS: More than 99% of arterial segments were found to be of diagnostic image quality by both readers in all dose groups. Generalized estimating equation analysis showed a significant difference among the three groups with regard to vessel definition (P = .019). No significant difference was found between the high- and intermediate-dose groups; however, the low-dose group had significantly better vessel definition compared with the high-dose (P = .034) and intermediate-dose (P = .015) groups. There was no significant difference among the groups in visualization of collateral vessels. Venous contamination was seen less frequently in the low-dose group, but the difference did not achieve significance. CONCLUSION: The study showed that, compared with widely used dose strategies at 1.5 T, the contrast agent dose for 3.0-T lower extremity MR angiography can be reduced multifold without compromising image quality.

Hypervascular thyroid nodules on time-resolved MR angiography at 3 T: radiologic-pathologic correlation.

OBJECTIVE: Detection of a thyroid nodule, either incidental or as a result of related symptomatology, is an extremely common event, often inducing considerable uncertainty regarding the requirement for and best means of further investigation. Whereas tissue sampling represents the sole means of true characterization of these lesions, a number of imaging characteristics have been suggested as potential indicators of the presence of malignancy. The potential value of time-resolved MR angiography, whereby a minimal dose of i.v. contrast agent is dynamically depicted during the first pass of the bolus through the various compartments of circulation, has recently been realized, particularly so with regard to supraaortic angiography. However, it is not uncommon during such temporal imaging to identify focal hyperenhancing thyroid nodules, the significance of which has not previously been described in the literature. We describe the frequency of occurrence and potential significance of this finding, using pathologic correlation where available. CONCLUSION: The prevalence of malignancy in incidentally detected focal hyperenhancing thyroid parenchymal nodules during time-resolved MR angiography is significant, representing 8.3% (1/12) of patients for whom cytologic correlation was available. Further investigation is certainly warranted when encountering such a lesion in clinical practice, particularly because it appears as though time-resolved MR angiography is of no value in the pathologic discrimination of such incidentally identified lesions.

MR imaging of the thoracic aorta.

MR imaging has been incorporated into the diagnostic algorithm for suspected thoracic aortic pathology, challenging CT and invasive catheter angiography as investigations of choice. Techniques, including spin echo, 3-D steady-state free precession, cardiac cine imaging, phase-contrast flow quantification, and high-resolution contrast-enhanced magnetic resonance angiography, are poised to trump other single competitive modalities. The proliferation of 3-tesla systems has advanced the performance of magnetic resonance, aided by parallel imaging techniques, multiarray surface coils, and powerful gradient coils. This article considers the current status of MR imaging in evaluation of the thoracic aorta, with reference to common clinical indications in clinical practice.

Time-resolved MR angiography of the thorax.

Time-resolved magnetic resonance angiography (TR-MRA) has received considerable attention recently owing to its ability to provide a dynamic complement to otherwise "static" high-resolution 3-D contrast-enhanced MRA for a variety of clinical indications. Steady technologic advances, including ultrafast pulse sequences, phased multiarray surface coils, parallel data acquisition techniques, and the widespread availability of high-field magnetic resonance systems, have enhanced the clinical usefulness of TR-MRA. This article considers the current role of TR-MRA in thoracic imaging, illustrating many of its clinical applications, and potential future of this recent approach to noninvasive dynamic vascular evaluation.

Evaluation of coronary stents and stenoses at different heart rates with dual source spiral CT (DSCT).

OBJECTIVES: Evaluation of coronary arteries at higher heart rates and in the presence of coronary stents remains problematic. The utilization of dual source computed tomography (DSCT) might improve the visualization of the coronary arteries under these conditions by imaging at a temporal resolution of 83 milliseconds, independent of heart rate. MATERIALS AND METHODS: Vessel phantoms (diameter 2-4 mm) were attached to a robotic device to simulate cardiac motion and scanned with a DSCT system. The phantoms had either inserts leading to 50% stenosis or carried stents. Images were evaluated for motion artifacts and measurements of the normal, stenotic, and in-stent lumen at different heart rates (50-120 bpm) were performed. Quantile regression analysis was performed to investigate heart rate dependence of the measurement errors. RESULTS: Visualization of the stenoses and stents was possible without motion artifacts at heart rates of up to 120 bpm. Image quality was similar for the static (0 bpm) and the dynamic (50-120 bpm) scans. Errors for diameter measurements of the vessel lumen and the stenotic lumen were low (3-mm vessel: 1-2%), but considerable for in-stent diameter measurements (3-mm stent: 27-32%). A window/level setting of 1500/300 Hounsfield units was more favorable for stent evaluation. No heart rate dependence was found. CONCLUSIONS: Depiction of coronary stents with DSCT is possible across a large range of simulated heart rates without motion artifacts and with image quality superior to that of previous generations of CT scanners.

MR angiography at 3 T for assessment of the external carotid artery system.

OBJECTIVE: A number of clinical situations exist in which high-resolution depiction of the external carotid artery system is required, a task not previously addressed by MR angiography. The purpose of this study was to evaluate the extent to which high-spatial-resolution MR angiography at 3 T can be used to map the normal external carotid artery system. SUBJECTS AND METHODS: Twenty-three consenting adult patients were prospectively evaluated. Images acquired were evaluated by two independent observers, and each branch vessel was scored with regard to image quality, presence and grade of stenoses, and artifacts. Interobserver agreement regarding image quality and the presence and degree of stenosis was tested using the kappa coefficient. Differences in quality ratings between the two observers were assessed using the paired Student's t test. RESULTS: Of 828 vessels analyzed, 92.63% were designated of diagnostic quality with no significant difference between the observers' image quality scores (p = 0.63). Good agreement was determined regarding image quality achieved (kappa = 0.716). All examinations were free of artifact sufficient to interfere with confident interpretation. Excellent correlation was seen with regard to stenosis detection and grading (kappa = 0.857). Of the external carotid artery systems assessed, 82.6% showed conventional anatomic vascular branching. CONCLUSION: High-spatial-resolution, 3D contrast-enhanced MR angiography at 3 T using sagittal source data acquisition and an advanced acceleration factor of 6 allows high-quality (92.63% of arterial segments) visualization of the external carotid artery system, with complete head and neck vascular coverage.

Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system.

OBJECTIVE: The objective of our study was to investigate a multistation whole-body MR angiography (MRA) protocol using a 32-channel MR system with multicoil technology in a population of patients with suspected peripheral vascular disease (PVD). SUBJECTS AND METHODS: Fifty consecutive patients with suspected PVD (31 men, 19 women; age range, 46-91 years) underwent multistation whole-body contrast-enhanced MR angiography (CE-MRA) on a 32-channel 1.5-T MR system equipped with multicoil technology. A two-step contrast injection protocol was used: After the first injection, images of the most proximal station (station I, head and neck) were acquired, followed by the most distal station (station IV, calves). Images of the intermediate two stations (station II, chest and abdomen; station III, pelvis and thighs) were acquired during the second injection. Conventional catheter angiography was performed for symptomatic vascular regions in 30 patients. The image quality of the arterial segments and the presence and degree of the arterial stenosis were evaluated by two radiologists. The interobserver variability was calculated by kappa statistics, and comparative analysis between CE-MRA and catheter angiography was performed by means of the Spearman's rank correlation coefficient. RESULTS: Most of the vascular segments (1,912/1,976 [97%]) were visualized on wholebody CE-MRA with diagnostic image quality. Significant arterial disease (> or = 50%) was detected in 167 (observer 1) and 177 (observer 2) segments with excellent interobserver agreement (kappa = 0.84). There was a significant correlation between CE-MRA and conventional angiography for the degree of stenosis (R = 0.92 and 0.89 for observers 1 and 2, respectively). The sensitivity and specificity of CE-MRA for the detection of arterial stenoses 50% or greater were 92% and 96% for observer 1 and 93% and 97% for observer 2, respectively, compared with those of conventional angiography. CONCLUSION: Using a multichannel radiofrequency system with multicoil technology, the whole-body CE-MRA approach outlined in this article is able to provide high-spatial-resolution data sets with high diagnostic image quality for evaluation of arterial occlusive disease in most vascular territories.

Cardiac MR imaging: new advances and role of 3T.

Over the last decade, cardiac magnetic resonance imaging has increasingly evolved into a useful diagnostic tool among the radiology and cardiology communities. Ongoing improvements in MR imaging hardware, processing speed, and pulse sequence development have laid the foundation for rapid progress in cardiac MR imaging. This article summarizes developing techniques and technique-related aspects, and the advantages and possible pitfalls of 3T in particular.

High-spatial-resolution contrast-enhanced MR angiography of abdominal arteries with parallel acquisition at 3.0 T: initial experience in 32 patients.

OBJECTIVE: The objective of our study was to evaluate an isotropic high-spatial-resolution 3D contrast-enhanced MR angiography (CE-MRA) protocol with high acceleration parallel acquisition at 3.0 T for the display of the abdominal vasculature. SUBJECTS AND METHODS: Thirty-two consecutive patients (13 men, 19 women; age range, 28-88 years) with suspected abdominal arterial disease underwent abdominal 3D CE-MRA on a 3.0-T MR system, using a high-spatial-resolution (0.7 x 0.82 x 0.8 mm3) 3D gradient-refocused echo (GRE) sequence, integrated with a generalized autocalibrating partially parallel acquisitions (GRAPPA) technique with an acceleration factor of 3. Two vascular radiologists evaluated image quality and the presence and degree of arterial stenoses. Interobserver variability was calculated, using the kappa coefficient. The sensitivity and specificity of the technique were calculated and comparative analysis was performed with those of conventional catheter angiography (in eight patients) as the standard of reference. RESULTS: The abdominal arterial vasculature was visualized with diagnostic image quality in all subjects. Arterial stenoses were detected in 148 and 142 arterial segments by observer 1 and observer 2, respectively, with good interobserver agreement (kappa = 0.75; 95% confidence interval [CI]: 0.69-0.81). The sensitivity and specificity values for CE-MRA for the detection of significant (> 50%) arterial stenoses were 100% and 96% for observer 1 and 100% and 92% for observer 2, respectively. There was a significant correlation between CE-MRA and conventional angiography (R = 0.96 and 0.93 for observers 1 and 2, respectively) for the assessment of the degree of stenosis. CONCLUSION: The outlined MR angiography protocol at 3.0 T combined with parallel acquisition technique renders highly reliable and isotropic high-spatial-resolution imaging of the abdominal vasculature.

Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 tesla.

PURPOSE: To determine whether time-resolved magnetic resonance angiography (TR-MRA) with ultra-low-dose gadolinium chelate (1.5-3.0 mL) can reliably detect or rule out hemodynamically significant disease in the carotid-vertebral artery territory. MATERIALS AND METHODS: Hundred consecutive patients (62 women, 38 men, mean age = 56.6 years) underwent both TR-MRA and standard high-resolution contrast-enhanced magnetic resonance angiography (CE-MRA), having been randomized to 1 of 2 groups; group A receiving a contrast dose of 1.5 mL for TR-MRA and group B receiving 3.0 mL. For scoring purposes the arterial system was divided into 21 segments. All TR-MRA and CE-MRA studies were blindly assessed by 2 radiologists for overall image quality, segmental arterial visualization, grading of arterial stenosis/occlusion, and incidence and severity of artifact. TR-MRA findings were directly compared with those of the corresponding CE-MRA examinations. RESULTS: Group A TR-MRA studies were of significantly inferior overall image quality compared with those of the corresponding CE-MRA examinations (P = 0.01 for both observers). In group B, overall image quality was similar for TR-MRA and single-phase CE-MRA examinations. On a segmental basis, a higher number of "insufficient quality" segments were identified in group A TR-MRA studies than in group B. A similar reduction in the incidence of artifacts was observed for group B relative to group A TR-MRA studies. Both groups A and B TR-MRA studies were of high specificity, negative predictive values, and accuracy (>97%). CONCLUSION: Ultra-low dose TR-MRA may be performed with 3 mL of gadolinium chelate with preservation of overall image quality and arterial segmental visualization relative to single phase CE-MRA, whereas a 1.5 mL contrast dose is associated with more suboptimal studies. Nonetheless, even at doses as low as 1.5 mL, TR-MRA can exclude arterial stenosis or occlusion.

Current status of 3-T cardiovascular magnetic resonance imaging.

Continued advances in radiofrequency hardware and tailored software have, in recent times, greatly increased the power and performance of magnetic resonance imaging for noninvasive evaluation of cardiovascular diseases. Magnetic resonance imaging can uniquely be manipulated to trade temporal resolution and spatial resolution against each other, depending on whether detailed structural or functional information is required. However, to date, a number of cardiovascular magnetic resonance applications have been somewhat limited due to signal-to-noise ratio constraints, reflecting the narrow imaging window imposed by physiological cardiac motion. By increasing the operating field strength from 1.5 to 3 T, it is possible (in principle) to double the signal-to-noise ratio, which in turn may be "traded" for improvements in spatial resolution, coverage, or imaging speed. In this context, the development of parallel imaging has set the stage for impressive performance improvements in contrast-enhanced magnetic resonance angiography at 3 T. Indeed, one could argue that without parallel acquisition, the bang for the buck in going from 1.5 to 3 T would be limited. In this paper, we discuss the current status of 3-T magnetic resonance imaging for cardiovascular imaging, considering the relative gains and limitations relative to 1.5 T.

Whole-body magnetic resonance angiography at 3.0 Tesla.

The quality of magnetic resonance (MR) angiography could be substantially improved over the past several years based on the introduction and application of parallel imaging, new sequence techniques, such as, e.g., centric k-space trajectories, dedicated contrast agents, and clinical high-field scanners. All of these techniques have played an important role to improve image resolution or decrease acquisition time for the dedicated examination of a single vascular territory. However, whole-body MR angiography may be the application with the potential to profit most from these technical advances. The present review article describes the technical innovations with a focus on parallel imaging at high field strength and the impact on whole-body MR angiography. The clinical value of advanced whole-body MR angiography techniques is illustrated by characteristic cases.

Assessment of cerebral arteriovenous malformations with high temporal and spatial resolution contrast-enhanced magnetic resonance angiography: a review from protocol to clinical application.

The combination of high spatial and high temporal resolution contrast-enhanced magnetic resonance angiography (MRA) at 3.0 T has enabled the detailed evaluation of functional vascular anatomy and hemodynamics of cerebral arteriovenous malformations (AVMs). Key contributory technical factors for the successful implementation of MRA in patients with different vascular pathologies are multicoil and multichannel receiver arrays, which enable higher parallel acquisition at 3.0 T over a uniform and a large field of view for highly temporally and spatially resolved MRA. Magnetic resonance angiography enables both screening of patients with suspected AVMs and follow-up of patients after therapy. It allows the characterization of AVMs with respect to nidus configuration, size, venous drainage, and so on, according to the Spetzler-Martin classification.

Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children.

PURPOSE: To retrospectively determine if controlled apnea improves the image quality of contrast material--enhanced magnetic resonance (MR) angiography of the chest and abdomen in children. MATERIALS AND METHODS: Institutional review board approval and waiver of informed consent were obtained for this HIPAA-compliant study. The authors evaluated contrast-enhanced MR angiographic procedures performed in the chest, abdomen, or both, in 23 children (14 boys, nine girls; age range, 1 month to 8 years) who were under general anesthesia. All patients underwent mechanical ventilation with preoxygenation (100% oxygen) prior to controlled apnea during image acquisition. In control subjects, the authors assessed contrast-enhanced MR angiographic procedures performed in the chest, abdomen, or both, in 23 children (matched for age and type of study with children in the controlled apnea group; 11 boys, 12 girls; age range, 1 month to 8 years) who were under general anesthesia (n=15) or deep sedation (n=8) and were breathing spontaneously during image acquisition. MR angiograms of the chest, abdomen, or both, were assessed for image quality, motion artifacts, and vessel definition by two radiologists working in consensus with a subjective grading scale. Wilcoxon signed rank test was used to assess differences in measurements. RESULTS: Image quality was rated excellent in 97% (30 of 31) of studies with controlled apnea and in 30% (nine of 31) of control studies (P<.001). Motion artifacts were absent in 97% (30 of 31) of studies with controlled apnea and 13% (four of 31) of control studies (P<.001). Vessel sharpness was rated as being significantly better on images obtained with controlled apnea (P<.05). There were no complications caused by anesthesia or sedation in either group. CONCLUSION: Controlled apnea is highly effective in children for eliminating respiratory motion artifacts with contrast-enhanced MR angiographic studies, resulting in greatly improved image quality and spatial resolution.

Pulmonary MR perfusion at 3.0 Tesla using a blood pool contrast agent: Initial results in a swine model.

PURPOSE: To prospectively evaluate the technical feasibility of a highly accelerated pulmonary MR perfusion protocol at 3.0T using a blood pool contrast agent in a swine model. MATERIALS AND METHODS: Twelve pigs underwent time-resolved pulmonary MR angiography (MRA) on a 3.0T MR system under anesthesia and controlled mechanical ventilation. After intravenous injection of 0.05 mmol/kg of Gadomer-17 at 4 mL/second, a fast time-resolved MRA sequence with temporal echo-sharing (three segmented k-space) and highly accelerated parallel acquisition was used to acquire 3D data sets with an in-plane resolution of 1 x 1 mm(2) (slice thickness = 6 mm) and temporal resolution of one second. Image quality was evaluated independently by two radiologists, and quantitative analysis of perfusion parameters was performed using pre-released perfusion software. RESULTS: All studies were identified by both readers as having diagnostic image quality (range = 2-3, median = 3) and there was excellent interobserver agreement (kappa = 0.89; 95% CI = 0.83, 0.95). A quantitative analysis of perfusion indices was performed, with excellent overall goodness-of-fit (chi(2) value = 1.4, degree of freedom (DF) = 1). Successfully derived perfusion parameters included the time to peak (TTP, 5.1 +/- 0.7 second), mean transit time (MTT, 6.6 +/- 0.9 second), maximal signal intensity (MSI, 1051.2 +/- 718.9 arbitrary units [A.U.]), and maximal upslope of the curve (MUS, 375.9 +/- 263.4 A.U./second). CONCLUSION: 3.0T pulmonary MR perfusion using a blood pool contrast agent in a swine model is feasible. The higher available signal-to-noise ratio (SNR) at 3.0T and the high T1 relaxivity of Gadomer-17 effectively support highly accelerated parallel acquisition, and improve the performance of time-resolved pulmonary MRA.

Juvenile and adult congenital heart disease: time-resolved 3D contrast-enhanced MR angiography.

PURPOSE: To assess the incremental diagnostic value of time-resolved three-dimensional (3D) magnetic resonance (MR) angiography over single-phase 3D MR angiography and cine MR imaging in juvenile and adult patients with congenital heart disease (CHD). MATERIALS AND METHODS: The study was HIPAA compliant and was approved by the institutional review board. Written informed consent was obtained from each patient. Eighty-one consecutive patients (46 male and 35 female patients; mean age, 31.1 years +/- 13.5 [standard deviation]) with CHD were examined with a 1.5-T MR imaging unit. The imaging protocol comprised time-resolved MR angiography (repetition time msec/echo time msec, 2.01/0.81) after injection of 0.03 mmol gadodiamide per kilogram of body weight at 4 mL/sec and single-phase high-spatial-resolution MR angiography (2.87/0.97) after injection of 0.15 mmol/kg gadodiamide at 1.5 mL/sec. After review of the time-resolved and conventional MR angiographic data sets, each of two independent observers listed the additional clinical information gained from time-resolved MR angiographic data. A Wilcoxon signed rank test was used to test for statistical differences between the image quality ratings of the two observers. RESULTS: Time-resolved and single-phase high-spatial-resolution MR angiography yielded diagnostic image data in all patients. Observers 1 and 2 found functional information in time-resolved MR angiographic series in 52 and 51 patients, respectively, that was not seen at high-spatial-resolution MR angiography. Intra- and extracardiac shunts, respectively, were exclusively depicted by time-resolved MR angiography for observer 1 in 18 and two patients and for observer 2 in 15 and two patients. However, both observers reported higher confidence in the assessment of such smaller vascular structures as supraaortic vessels (in 12 patients for observer 1 and 11 patients for observer 2) and major aortopulmonary collateral arteries (in eight patients for observer 1 and 10 patients for observer 2) at high-spatial-resolution MR angiography. No significant difference was evident in image quality scoring between the two observers (P = .32 for time-resolved and P = .47 for conventional MR angiography). CONCLUSION: Compared with conventional MR angiography, time-resolved MR angiography yields clinically relevant information in a substantial number of patients; hence, the two techniques should be regarded as complementary.

MR imaging with remote control: feasibility study in cardiovascular disease.

The institutional review board approved this HIPAA-compliant study and waived informed consent. The purpose was to retrospectively evaluate remote control magnetic resonance (MR) imaging in complex cardiovascular procedures, whereby operational expertise was made available locally from a remote location. Thirty patients underwent cardiac (12 patients) and/or vascular (30 patients) 1.5-T MR imaging with a remote operator by using a personal computer. All patient studies were compared with 30 control studies obtained with conventional local imaging. Cardiac cine, myocardial delayed enhancement, and MR angiograms were assessed for overall image quality and motion artifact. MR angiograms were evaluated for vascular definition. Image quality was excellent in 90% (38 of 42) of remote images versus 60% (25 of 42) of control group images (P < .01). Scores for motion artifact were not significantly different (P = .11). Interactive MR imaging was successfully implemented with remote control in complex cardiovascular cases; diagnostic quality of images was superior to that of images obtained locally.